Scholar Rock Holding Corporation

SRRK Healthcare Biotechnology

Scholar Rock Holding Corporation’s revenue for fiscal 2022 (year ended December 2022) was $33.2 million. In the quarter to June 2026, EPS grew 14.3%, free cash flow grew 8.88% and total debt rose 294.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

39.85 0.79 −1.94%
Market cap
$5.0B
P/E
0.0×
Fwd P/E
−7.3×
Dividend yield
—
F-score
3/9
Altman Z
1.14
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
390.71 385.15 515.28 507.18
Total non-current assets
21.01 19.13 19.97 16.36
Total Assets
411.72 404.27 535.25 523.54
Total current liabilities
61.97 55.42 59.64 72.24
Total non-current liabilities
104.75 103.37 199.60 197.52
Total liabilities
166.72 158.78 259.24 269.76
Common Equity (Total)
245.00 245.49 276.01 253.78
Shareholders Equity (Total)
245.00 245.49 276.01 253.78
Total Debt
99.61 99.71 196.61 196.20

Show all line items

In millions of $ except per-share values · columns are period end dates